3Shang W, Y Yang, B Jiang, et al. Ginsenoside RbI promotes adipogenesis in 3T3-L1 ceils by enhancing PPARgamma2 and C/ EBPalpha gene expression[ J]. Life Sci, 2007, 80(7) :618.
4Shang W, Yang Y, Zhou L, et al. Ginsenoside RbI stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes [ J ]. J Endocrinol, 2008, 198 ( 3 ) :561.
5Salmon D M, J P Flatt. Effect of dietary fat content on the inci- dence of obesity among ad libitum fed mice [ J ]. Int J Obes, 1985, 9(6) :443.
6Bays H, L Mandarino, R A DeFronzo. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists pro- vide a rational therapeutic approach [ J ]. J Clin Endocrinol Metab, 2004, 89(2) :463.
7Langin D. Adipose tissue lipolysis as a metabolic pathway to de-fine pharmacological strategies against obesity and the metabolic syndrome[J]. Pharmacol Res, 2006, 53(6) :482.
8den Boer M, P J Voshol, F Kuipers, et al. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models [J]. Arterioscler Tbromb Vasc Biol, 2004, 24(4) :644.
9Duncan R E, M Ahmadian, K Jaworski, et al. Regulation of li-polysis in adipoeytes[ J ]. Annu Rev Nutr, 2007, 27:79.
10Item F, D Konrad. Visceral fat and metabolic inflammation: the portal theory revisited[ J. Obes Rev, 2012, 13 (Suppl 2) :30.
